Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-26 @ 1:16 PM
Study NCT ID:
NCT03436693
Status:
COMPLETED
Last Update Posted:
2024-07-15
First Post:
2018-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy
Sponsor:
Tanabe Pharma Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-21
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-01
First Submit QC Date:
None
Study First Post Date:
2018-02-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-30
Results First Submit QC Date:
None
Results First Post Date:
2024-07-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-28
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ACTUAL